- Low clinical utility of testing for anti-platelet factor 4 in asymptomatic individuals after ChAdOx1 nCoV-19 vaccine. Barefah AS, Radhwi OO, Alamri SS, Alahwal HM, Denetiu I, Almohammadi AT, Bahashwan SM, Qari MH, Algaissi A, Alamer E, Alhazmi A, Abuzenadah AM, Nasraldeen WH, Alzahrani SH, Hashem AM. Low clinical utility of testing for anti-platelet factor 4 in asymptomatic individuals after ChAdOx1 nCoV-19 vaccine. Int J Lab Hematol. 2022 Apr;44(2):424-429. doi: 10.1111/ijlh.13774. Epub 2021 Nov 30. PMID: 34850575.
- TP53 Expression and Mutational Analysis in Hematological Malignancy in Jeddah, Saudi Arabia. Alkhatabi H, Yasin EB, Mirza Z, Alserihi R, Felimban R, Elaimi A, Shaabad M, Alharbi L, Ahmed H, Alameer AM, Mathkoor AE, Barefah AS. TP53 Expression and Mutational Analysis in Hematological Malignancy in Jeddah, Saudi Arabia. Diagnostics (Basel). 2022 Mar 16;12(3):724. doi: 10.3390/diagnostics12030724. PMID: 35328276; PMCID: PMC8946951.
- A Smart Chatbot for Interactive Management in Beta Thalassemia Patients. Alturaiki AM, Banjar HR, Barefah AS, Alnajjar SA, Hindawi S. A Smart Chatbot for Interactive Management in Beta Thalassemia Patients. Int J Telemed Appl. 2022 May 11;2022:9734518. doi: 10.1155/2022/9734518. PMID: 35601050; PMCID: PMC9117039.
- Immunogenicity of The BNT162b2 COVID-19 mRNA and ChAdOx1 nCoV-19 Vaccines in Patients with Hemoglobinopathies. Radhwi OO, Jan H, Waheeb A, Alamri SS, Alahwal HM, Denetiu I, Almanzlawey A, Al-Marzouki AF, Almohammadi AT, Bahashwan SM, Barefah AS, Qari MH, Abuzenadah AM, Hashem AM. Immunogenicity of The BNT162b2 COVID-19 mRNA and ChAdOx1 nCoV-19 Vaccines in Patients with Hemoglobinopathies. Vaccines (Basel). 2022 Jan 20;10(2):151. doi: 10.3390/vaccines10020151. PMID: 35214610; PMCID: PMC8877446.
- Methylation of the suppressor of Cytokine Signaling 1 Gene (SOCS1) in Philadelphia-negative myeloproliferative neoplasms. Yasin EB, Alserihi R, Alkhatabi H, Qutob HMH, Qahwaji R, Kattan SW, Gholam KA, Hussein E, Barefah AS, Alghuthami ME, Abuzenadah A. Methylation of the suppressor of Cytokine Signaling 1 Gene (SOCS1) in Philadelphia-negative myeloproliferative neoplasms. Eur Rev Med Pharmacol Sci. 2022 Nov;26(22):8451-8458. doi: 10.26355/eurrev_202211_30381. PMID: 36459028.
- Primary Central Nervous System Burkitt Lymphoma, Presenting with Long-Term Fluctuating Level of Consciousness: A Case Report and Literature Review on Challenges in Diagnosis and Management. Bahashwan SM, Radhwi OO, Alahwal HM, Almohammadi AT, Barefah AS, Daous YM, Alghamdi FA. Primary Central Nervous System Burkitt Lymphoma, Presenting with Long-Term Fluctuating Level of Consciousness: A Case Report and Literature Review on Challenges in Diagnosis and Management. Am J Case Rep. 2022 Jun 21;23:e936401. doi: 10.12659/AJCR.936401. PMID: 35727738; PMCID: PMC9235913.
- COVID-19 Vaccine Perception and Hesitancy Among Patients With Sickle Cell Disease in the Western Region of Saudi Arabia. Jan H, Waheeb A, AlAhwal H, Almohammadi A, Al-Marzouki A, Barefah A, Bahashawan S, Radhwi O. COVID-19 Vaccine Perception and Hesitancy Among Patients With Sickle Cell Disease in the Western Region of Saudi Arabia. Cureus. 2022 Jan 8;14(1):e21026. doi: 10.7759/cureus.21026. PMID: 35154996; PMCID: PMC8820497.
- Reticulocyte Hemoglobin-Equivalent Potentially Detects, Diagnoses and Discriminates between Stages of Iron Deficiency with High Sensitivity and Specificity. Almashjary MN, Barefah AS, Bahashwan S, Ashankyty I, ElFayoumi R, Alzahrani M, Assaqaf DM, Aljabri RS, Aljohani AY, Muslim R, Baawad SA, Bawazir WM, Alharthy SA. Reticulocyte Hemoglobin-Equivalent Potentially Detects, Diagnoses and Discriminates between Stages of Iron Deficiency with High Sensitivity and Specificity. J Clin Med. 2022 Sep 26;11(19):5675. doi: 10.3390/jcm11195675. PMID: 36233545; PMCID: PMC9572493.
- Lack of Evidence on Association between Iron Deficiency and COVID-19 Vaccine-Induced Neutralizing Humoral Immunity. Faizo AA, Bawazir AA, Almashjary MN, Hassan AM, Qashqari FS, Barefah AS, El-Kafrawy SA, Alandijany TA, Azhar EI. Lack of Evidence on Association between Iron Deficiency and COVID-19 Vaccine-Induced Neutralizing Humoral Immunity. Vaccines (Basel). 2023 Feb 1;11(2):327. doi: 10.3390/vaccines11020327. PMID: 36851205; PMCID: PMC9965425.
-
Incidence and Risk Factors of Infections Among Diffuse Large B-cell Lymphoma and Classical Hodgkin's Lymphoma Patients in a Tertiary Care Center in Saudi Arabia: A Retrospective Cohort Study.
Alelyani RH, Alghamdi AH, Almughamisi TA, Alshareef AM, Kadasa AN, Alrajhi AM, Alburayk AK, Barefah AS, Radhwi OO, Almohammadi AT, Bahashawan SM, AlAhwal HM. Incidence and Risk Factors of Infections Among Diffuse Large B-cell Lymphoma and Classical Hodgkin's Lymphoma Patients in a Tertiary Care Center in Saudi Arabia: A Retrospective Cohort Study. Cureus. 2023 Mar 9;15(3):e35922. doi: 10.7759/cureus.35922. PMID: 36911585; PMCID: PMC9996399.
-
Chest computed tomographic findings in patients with sickle cell disease–related acute chest syndrome: A retrospective study
Alsilmi R, Alghamdi S, Alghamdi S, Alshahrani R, Alyoubi A, Almassari O, Alshaikhi M, Barefah A, Ajlan A, Eskander A, Jabali F. Chest computed tomographic findings in patients with sickle cell disease–related acute chest syndrome: A retrospective study.
-
Quality of systematic reviews/meta-analyses in coronavirus disease 2019 and venous thromboembolism: An analysis using a measurement tool to assess …
Alkhamesi S, Almohammadi A, Alahwal H, Barefah A, Bahashwan S, Radhwi O. Quality of systematic reviews/meta-analyses in coronavirus disease 2019 and venous thromboembolism: An analysis using a measurement tool to assess systematic reviews-2. Journal of Applied Hematology. 2022 Oct 1;13(4):222.
-
Impact of COVID-19 Pandemic on Treatment Decisions of Patients Treated by Hematologists in Saudi Arabia
Bahashwan SM, Alahwal HM, Almohammadi AT, Radhwi OO, Khan SA, Barefah AS. Impact of COVID-19 Pandemic on Treatment Decisions of Patients Treated by Hematologists in Saudi Arabia. Journal of Applied Hematology. 2023 Jan 1;14(1):7.
-
Web-based expert system with quick response code for beta-thalassemia management.
Banjar HR, Zaher GF, Almutiry HS, Alshamarni ASA, Almouhana GI, Alahwal HM, Bahashwan S, Barefah AS, Alnajjar SA, Alharbi HM. Web-based expert system with quick response code for beta-thalassemia management. Health Informatics J. 2021 Jan-Mar;27(1):1460458221989397. doi: 10.1177/1460458221989397. PMID: 33570008.
-
The risk of venous thromboembolism in patients with clinically overt gastrointestinal bleeding.
Almakadi M, Sheasgreen C, Barefah A, Lu L, Kumar Tyagi N, Mazzetti G, Crabbe L, Yuan Y, Crowther M, Leontiadis G. The risk of venous thromboembolism in patients with clinically overt gastrointestinal bleeding. Am J Hematol. 2018 Feb;93(2):E42-E45. doi: 10.1002/ajh.24967. Epub 2017 Nov 22. PMID: 29119605.
-
Tumour lysis syndrome in a patient with undifferentiated endometrial stromal sarcoma.
Ahmed Z, Barefah A, Wasi P, Jones G, Ramsay J. Tumour lysis syndrome in a patient with undifferentiated endometrial stromal sarcoma. Gynecol Oncol Rep. 2019 Feb 15;28:41-43. doi: 10.1016/j.gore.2019.02.006. PMID: 30834285; PMCID: PMC6384315.
-
Saudi Lymphoma Group's Clinical Practice Guidelines for Diagnosis, Management and Follow-up of Patients with Various Types of Lymphoma during the Coronavirus Disease 2019 Pandemic.
Alzahrani M, Al-Mansour MM, Apostolidis J, Barefah A, Dada R, Alhejazi A, Alayed Y, Motabi I, Radwi M, Al-Hashmi H. Saudi Lymphoma Group's Clinical Practice Guidelines for Diagnosis, Management and Follow-up of Patients with Various Types of Lymphoma during the Coronavirus Disease 2019 Pandemic. Saudi J Med Med Sci. 2020 Sep-Dec;8(3):227-238. doi: 10.4103/sjmms.sjmms_457_20. Epub 2020 Aug 20. PMID: 32952517; PMCID: PMC7485653.
-
Resident reflections on end-of-life education: a mixed-methods study of the 3 Wishes Project.
Centofanti J, Swinton M, Dionne J, Barefah A, Boyle A, Woods A, Shears M, Heels-Ansdell D, Cook D. Resident reflections on end-of-life education: a mixed-methods study of the 3 Wishes Project. BMJ Open. 2016 Mar 31;6(3):e010626. doi: 10.1136/bmjopen-2015-010626. PMID: 27033962; PMCID: PMC4823392.
